Ken Griffin Sol Gel Technologies Ltd. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 20,100 shares of SLGL stock, worth $147,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,100
Previous 12,800
57.03%
Holding current value
$147,735
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SLGL
# of Institutions
25Shares Held
5.38MCall Options Held
20.1KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$18.2 Million0.02% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$9.02 Million0.01% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$6.76 Million0.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3227KShares$1.67 Million0.02% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL112KShares$822,8470.0% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $170M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...